Given their significant role in cancer progression, MMPs are considered potential therapeutic targets. Several MMP inhibitors (MMPIs) have been developed, but their clinical success has been limited due to issues such as lack of specificity and adverse side effects. Ongoing research aims to develop more selective and effective MMPIs.
